Summary
Zoetis Inc. reported solid performance for the second quarter and the first half of 2014, with total revenue increasing by 4% and 6% respectively compared to the prior year periods. This growth was driven by operational improvements, including a 3% volume increase and a 3% price increase in the second quarter, and a 3% volume and 2% price increase in the first half. The company demonstrated strong performance across its geographic segments, particularly in the U.S. and emerging markets like Brazil and China. Livestock sales saw a significant increase, while companion animal sales also showed positive growth, supported by new product introductions and price adjustments in high-inflation markets. Despite revenue growth, net income attributable to Zoetis Inc. saw a more modest increase of 6% and 9% for the respective periods, reaching $136 million and $291 million. This was partly due to increased expenses in certain areas such as the build-up of enabling functions post-separation from Pfizer, and higher foreign currency losses impacting the "Other (income)/deductions—net" line. The company also navigated the complexities of its recent separation from Pfizer, incurring associated costs while managing its standalone operations. Zoetis maintained a strong liquidity position with significant cash and cash equivalents and manageable debt levels.
Financial Highlights
51 data points| Revenue | $1.16B |
| Cost of Revenue | $413.00M |
| Gross Profit | $745.00M |
| SG&A Expenses | $396.00M |
| Operating Expenses | $953.00M |
| Interest Expense | $29.00M |
| Net Income | $139.00M |
| EPS (Basic) | $0.27 |
| EPS (Diluted) | $0.27 |
| Shares Outstanding (Basic) | 500.98M |
| Shares Outstanding (Diluted) | 501.68M |
Key Highlights
- 1Revenue increased by 4% to $1,158 million for the three months ended June 29, 2014, and by 2% to $2,255 million for the six months ended June 29, 2014, compared to the prior year periods.
- 2Net income attributable to Zoetis Inc. grew by 6% to $136 million for the quarter and 9% to $291 million for the six months, indicating profitable growth.
- 3Operational revenue growth was 6% in the second quarter and 5% in the first half, driven by a combination of volume and price increases across segments.
- 4The U.S. segment showed strong revenue growth of 5% for the quarter and 5% for the six months, contributing significantly to overall performance.
- 5Livestock sales increased 9% operationally for the quarter and 6% for the six months, driven by strong performance in cattle and poultry portfolios.
- 6The company maintained a healthy balance sheet with $578 million in cash and cash equivalents and total assets of $6,522 million as of June 29, 2014.
- 7Foreign exchange rates had an unfavorable impact on revenue, decreasing it by approximately 2% ($23 million) in the second quarter and 3% ($55 million) in the first half.